A_DT
low_JJ
NM23_NNP
._.
H1_NNP
gene_NN
expression_NN
identifying_VBG
high_JJ
malignancy_NN
human_JJ
melanomas_NNS
._.

The_DT
NM23_NN
gene_NN
has_VBZ
been_VBN
proposed_VBN
as_IN
a_DT
metastasis-suppressor_JJ
gene_NN
,_,
and_CC
its_PRP$
use_NN
has_VBZ
been_VBN
suggested_VBN
as_IN
prognostic_JJ
factor_NN
._.

NM23_NN
was_VBD
identified_VBN
in_IN
a_DT
system_NN
of_IN
murine_JJ
melanoma_NN
cell_NN
lines_NNS
,_,
in_IN
which_WDT
an_DT
inverse_JJ
relationship_NN
was_VBD
found_VBN
between_IN
NM23_NN
expression_NN
and_CC
metastatic_JJ
ability_NN
._.

In_IN
a_DT
human_JJ
malignant_JJ
melanoma_NN
study_NN
NM23_NN
expression_NN
was_VBD
found_VBN
to_TO
be_VB
significantly_RB
lower_JJR
in_IN
metastases_NNS
that_WDT
developed_VBD
less_JJR
than_IN
24_CD
months_NNS
after_IN
diagnosis_NN
of_IN
the_DT
primary_JJ
tumors_NNS
._.

The_DT
present_JJ
paper_NN
studies_VBZ
the_DT
expression_NN
of_IN
the_DT
NM23_NN
._.
H1_NN
gene_NN
in_IN
cell_NN
lines_NNS
which_WDT
derive_VBP
from_IN
primary_JJ
or_CC
metastatic_JJ
human_JJ
malignant_JJ
melanomas_NNS
in_IN
relation_NN
to_TO
staging_NN
,_,
infiltration_NN
degree_NN
,_,
lymphocytic_JJ
infiltration_NN
,_,
cell_NN
morphology_NN
,_,
cell_NN
pigmentation_NN
,_,
karyotype_NN
,_,
and_CC
disease-free_JJ
survival_NN
._.

The_DT
level_NN
of_IN
mRNA_NN
expression_NN
of_IN
the_DT
NM23_NN
gene_NN
is_VBZ
significantly_RB
lower_JJR
in_IN
cell_NN
lines_NNS
that_WDT
derive_VBP
from_IN
more_RBR
infiltrating_JJ
primary_JJ
melanomas_NNS
than_IN
in_IN
cell_NN
lines_NNS
obtained_VBN
from_IN
less_JJR
infiltrating_VBG
tumors_NNS
._.

Moreover_RB
,_,
cell_NN
lines_NNS
derived_VBN
from_IN
tumors_NNS
of_IN
patients_NNS
with_IN
a_DT
disease-free_JJ
survival_NN
of_IN
more_JJR
than_IN
24_CD
months_NNS
-LRB-_-LRB-
24-58_CD
months_NNS
-RRB-_-RRB-
express_VBP
the_DT
NM23_NN
gene_NN
at_IN
higher_JJR
levels_NNS
than_IN
cell_NN
lines_NNS
obtained_VBN
from_IN
melanomas_NNS
of_IN
patients_NNS
with_IN
a_DT
disease-free_JJ
survival_NN
of_IN
less_JJR
than_IN
24_CD
months_NNS
-LRB-_-LRB-
6-15_CD
months_NNS
-RRB-_-RRB-
._.

